Table 6 Clinical features of the 106 recipients post-OLT
From: Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
Liver transplanted patients | |||||
|---|---|---|---|---|---|
HCV recurrence | Non-recurrence | P value | |||
Mean | SD | Mean | SD | ||
Age | 50.44 | 7.22 | 50.06 | 7.48 | 0.771 |
MELD | 17.12 | 1.88 | 17.15 | 1.86 | 0.913 |
Age of donor | 30.94 | 5.86 | 29.90 | 4.44 | 0.335 |
Donor steatosis % | 3.81 | 2.82 | 2.23 | 2.09 | 0.009 |
HCV RNA before (IU/ml) | 564.05 | 382.79 | 571.26 | 527.23 | 0.57 |
HCV RNA post (IU/ml) | 1806.20 | 918.0 | 120.97 | 888.48 | 0.002 |